As CEO of Evonetix, Colin will focus on building strategic partnerships and customer relationships, ahead of the commercial introduction of the Companys first benchtop DNA printer. She also acted as a Consultant for projects in collaboration with Genomics England, Technology Development and Applications, and Customer Support. Hermann holds an MA in Physics from Vienna University and a PhD in Physics from the University of Cambridge. Were excited to support the teams vision for transforming industrial workplaces. Evonetixs proprietary process utilises a novel silicon chip to control the synthesis of DNA at many thousands of independent thermally controlled reaction sites, or pixels, on the chip surface. CAMBRIDGE, United Kingdom-- ( BUSINESS WIRE )--EVONETIX LTD ('Evonetix'), the synthetic biology company developing a desktop platform for . EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. You're more than your latest funding, tell our customers your company's story. Investors - Evonetix By combining DNA polymer synthesis technology, electronic nano-switches and semiconductor fabrication technologies, Iridia is developing a highly-parallel format to enable an array of nanomodules with the potential to store data at exceptionally high density. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. The streaming video giant is slated to give investors its first-quarter earnings update in . Trevor was also responsible for the Industrialisation of new developments including Characterisation, Qualification and Production Test. Sources. Evonetix recently closed $24 million financing in an oversubscribed round led by Foresite Capital. Stock Market | Finance For specific trademark information, see www.evonetix.com/legal, Today is National #DNA Day! KioBaser is building what it dubs "Nespresso machine of DNA synthesis". Dr. Vishal Gulati is one of the Europes leading digital healthcare investors. It offers a connected worker platform providing job instruction and collaboration for frontline teams, and a no-code toolkit designed to accelerate the digital transformation of daily operations. Morningside, DCVC, Cambridge Consultants, Civilization Ventures, and Providence also participating and follows Evonetix's 23million . We have designed novelsemiconductor technologycapable of synthesising thousands of independent sequences across the surface of a single chip, re-engineered phosphoramidite chemistryto enable thermal control of the synthesis cycle, developednew ways to assemble DNAinto genes and established novel approaches toenzymatic DNAsynthesis. See our privacy policy for more information regarding 6senses The technical storage or access that is used exclusively for statistical purposes. Evonetix serves customers in the United Kingdom. Find useful insights on Evonetix's company details, tech stack, news alerts, competitors and more. In 40 year career as an entrepreneur and venture capitalist, Hermann has helped start a number of technology companies, including Acorn Computers and its spin-out ARM, as well as Cambridge Silicon Radio and next-generation DNA sequencing technology company Solexa, which became the market leader and was later acquired by Illumina. He has written for a range of publications including a column for the New York Times and articles for many other newspapers and magazines like The Economist, The Financial Times, The Boston Globe and The Believer. Helixworks Technologies is a biotechnology company specializing in DNA synthesis. Dr Matthew Hayes is the Chief Technology Officer of Evonetix and was a founding member of the Head of Software, Dan, joined Evonetix at its founding in 2015. He is currently on the boards of Horizon Discovery PLC and EcoEos. 1 Beauty Stock to Help Give Your Porftolio a Makeover The machine creates DNA primers, a short single strand of RNA or DNA (generally about 18-22 bases) that serves as a starting point for DNA synthesis. you agree to our privacy policy. Round. This approach enables the accurate synthesis of thousands of sequences on a single chip to meet the demand for complex libraries and assembly of long DNA in days rather than weeks, accelerating research across the exciting field of synthetic biology. Company profile page for Evonetix Ltd including stock price, company news, press releases, executives, board members, and contact information He holds a masters degree in electronic systems engineering from the University of York and is a Fellow of the Institution of Engineering and Technology. Evonetix raises $24 million for DNA synthesis - cen.acs.org August 16, 2022 at 05:13 AM EDT. In addition to publishing nearly 600 peer-reviewed scientific papers, he is the author of several books that address scientific issues in the context of a broader humanist debate. Vishal is a qualified physician and chairman of the Digital Health Forum. This investment from Molten Ventures will allow us to scale our business to meet that demand and continue to invest deeply into creating an operational knowledge layer for workers, with operational data enabled by AI. He completed his PhD at the University of Cambridge. Date. Oversubscribed round led by Foresite Capital; Funding will enable development of DNA synthesis chip technology to commercial scale; EVONETIX LTD ('Evonetix'), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over USD $54 million (circa GB 44 million). Professor Sir David Klenerman is Professor of Biophysical Chemistry at the University of Cambridge, where he also earned his PhD. Mammen joined Cambridge Consultants as Chief Financial Officer in 2005. Evonetix Raises $24M in Extended Series B Funding Round We are seeing huge demand from manufacturers looking for solutions to help them transform their operations in the face of increasing pressures and a worsening skills gap. said Zaptic CEO, Richard Milnes. However, researchers are constrained by the tools of the last generation of DNA synthesis technology. He has also worked in operational and general management roles in both Toronto, Canada and Sydney , Australia. These job postings data can help you identify how fast the company is growing Valuation. Our desktop DNA synthesis platform . Prior to this, Mammen was an Executive Director and Regional Finance Director for the Asian business operations of Arthur D Little. Evonetix has raised $24 million to develop technology that assembles long strands of DNA on silicon chips using phosphoramidite chemistry. JavaScript Raquel is an experienced R&D leader with a track-record of taking new ideas from concept phase to commercialised products in the Next Generation Sequencing (NGS) space. His previous roles include Director level positions in Marketing and Product Management at Thermo Fisher Scientific and Arcis Biotechnology, leadership of the Cell and Molecular Research Tools business segment at GE Healthcare and head of Marketing & Business Development at Promega UK. Evonetix's latest funding round is Series B - II. The company was founded in 2015 and is based in Cambridge, U.K. Promote your product offering to tech buyers. Matt joined Evonetix in 2019, as Head of Mechanical Engineering, after spending 12 years at Cambridge Consultants. Let's dig . Cambridge Consultants has since grown from revenues of 17M in 2005 to revenues of 120M in 2021, with offices in the US, Singapore and Japan in addition to its headquarters in Cambridge, United Kingdom. All trademarks are the property of Evonetix Ltd. or their respective owners. About - Evonetix | UNLOCKING THE POWER OF BIOLOGY Privacy Act (CCPA), please email [emailprotected]. Operator of a biotechnology company intended to synthesize DNA at higher accuracy and scale. The Company develops technology that enables the parallel synthesis of DNA on silicon arrays. Before joining Evonetix, Raquel was at Solexa (then Illumina Inc.) from 2002 as a Protein Engineer and major contributor to its disruptive NGS technology. We will respond in accordance with the CCPA. Zyme Communications Golf's Greatest Holes: Golfing legend Paul McGinley takes television presenter Chris Hollins on a tour of the best golf courses in Ireland and Northern Ireland. Its unique no-code drag-and-drop functionality is claimed to ensure productivity, efficiency, and savings. Build a competitive intelligence sales and marketing strategy based on the data and stand out in the market. Researchers are invited to apply to receive DNA that has been synthesised using Evonetixs platform. Before joining Evonetix, Matthew was Head of Technology for the Global Medtech Division of Cambridge Consultants. This profile is based on publicly available information and is intended to be informative in nature. His investments include Napo Pharmaceuticals, Glenmark, Renovo, Phagenesis. Jim Tananbaum is the founder and chief executive officer of Foresite Capital, a U.S.-focused healthcare investment firm founded in 2011 that has $3 billion in assets under management. Prior to that, Raquel was a post-doctoral researcher in the Department of Chemical Engineering and Biotechnology, University of Cambridge, in the area of cancer gene therapy. . Evonetix is a Cambridge-based company developing a radically different approach to gene synthesis. Prior to joining Evonetix he was Senior Vice President and Chief Commercial Officer at Fluidigm Corp, where he was responsible for leading all commercial activities, driving revenue growth, and expanding the Companys global reach. Helixworks Technologies is a biotechnology company specializing in DNA synthesis. Use Slintel to connect with top decision-makers at Evonetix. Also, Molten Ventures joins Zaptics board of directors as part of the investment. Fulfilling the potential of synthetic biology demands new ways to achieve long, accurate DNA synthesis at unprecedented scale. Malcolm also worked in both the assurance and consultancy practices of PwC. This is a profile preview from the PitchBook Platform. Farfetch Stock: Bull vs. Bear. Investors. Finance. Developing a new paradigm for gene synthesis to facilitate the fast-growing and exciting field of synthetic biology. Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data. Get their email address, phone numbers, and other details from Linkedin or any website. 9a Coldhams Business Park, Norman Way Our unique technology allows us to buildlaboratory scale platforms with industrial scale capabilities. Evonetix General Information. Among his operational responsibilities at DCVC, he helps portfolio companies tell their stories. DCVC and its principals have supported brilliant people changing global-scale businesses for over twenty years, helping create tens of billions of dollars of wealth while also making the world a markedly better place. Evonetix - Products, Competitors, Financials, Employees, Headquarters Our network is truly global, with key advisors located in Silicon Valley, Cambridge and NY in the US, as well as Europe and Asia. You can find more about their employees through LinkedIn or their website using Evonetix is ready to meet these challenges and open the door to the exciting next phase of our development., To apply to be included in the early access program, please visit: www.evonetix.com/access, View source version on businesswire.com: https://www.businesswire.com/news/home/20220816005493/en/, Lorna Cuddon Get the full list, Morningstar Institutional Equity Research, Reaction duration control for reaction performed on biomolecule samples, Accessing data storage provided using double-stranded nucleic acid molecules, Co-Founder, Chief Technology Officer & Board Member. Evonetix Ltd - Company Profile and News - Bloomberg Markets He joined Cambridge Consultants in 2001, and was responsible for the leadership of many of their largest and most technically challenging projects. Copy and paste multiple symbols separated by . Roku (NASDAQ: ROKU) stock is trouncing the market so far in 2023, but that rally will soon be tested. Read more, Find prospects by the technologies they use. Log in Subscribe Evonetix Raises $24M in Extended Series B Funding Round . He holds a PhD and MEng in Electronic Engineering, both from Loughborough University. By continuing to use this site you are consenting to these choices. Investors of Evonetix include Cambridge Consultants, Morningside Ventures, Molten Ventures, DCVC, Civilization Ventures and 7 more. Install and uncover Evonetixs employee details in less than 30 secs. This technology mimics the way nature produces genetic code and enables enhanced performance while minimizing the use of harsh chemicals. The company develops a DNA and RNA synthesizer for molecular biology research purposes. Get the full list, Youre viewing 5 of 10 board members. By BioCentury Staff. Description. Jason Pontin is a Partner at DCVC, where his belief that emerging technologies and new scientific insights can solve urgent challenges and expand human possibilities inspires his investments in Deep Tech and life sciences companies. EquityZen Securities LLC (EquityZen Securities) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.